$116.14
0.160.14%
Last update: 11:16 AM
15 minutes delayed
Novartis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novartis using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-18 | $1.97 | $1.86 | 5.91 % |
Mar 2024 | 2024-04-23 | $1.80 | $1.69 | 6.51 % |
Dec 2023 | 2024-01-31 | $1.53 | $1.68 | -8.93 % |
Mar 2023 | 2023-04-25 | $1.71 | $1.55 | 10.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-18 | $12.51B | $12.28B | 1.89 % |
Mar 2024 | 2024-04-23 | $11.83B | $11.48B | 3.04 % |
Dec 2023 | 2024-01-31 | $11.42B | $11.56B | -1.19 % |
Sep 2023 | 2023-10-24 | $11.78B | $11.40B | 3.35 % |
Novartis (NVS) is scheduled to report earnings on October 29, 2024. The last reported earnings were for reported on July 18, 2024 for Q2.
The Actual EPS was $1.97, which beat the estimate of $1.86.
The Actual Revenue was $12.5B, which beat the estimate of $12.3B.
Browse earnings estimates, EPS, and revenue on all stocks.